Gastrointestinal Cancers Symposium

The latest news from ASCO GI, including researcher interviews and physician perspective.


Meeting News CoverageMeeting Highlights

Dutasteride may increase adherence to active surveillance in early stage prostate cancer

HemOnc Today, March 10, 2011
ASCO 2011 Genitourinary Cancers Symposium ORLANDO — Dutasteride increased adherence to active surveillance by nearly 40% in a cohort of men with…
Meeting News CoverageMeeting Highlights

More time may be required to reach expert level in robotic prostate surgery

HemOnc Today, March 10, 2011
ASCO 2011 Genitourinary Cancers Symposium ORLANDO — Surgeons may need to perform more than 1,500 robotic-assisted laparoscopic radical…
Meeting News CoverageMeeting HighlightsPerspective

Bicalutamide during and after radiation shows promise for post-radical prostatectomy

HemOnc Today, March 10, 2011
ASCO 2011 Genitourinary Cancers Symposium ORLANDO — The addition of bicalutamide to radiation therapy significantly improved OS and freedom from…
Meeting News CoverageMeeting HighlightsPerspective

Intermittent androgen suppression may be noninferior to continuous androgen deprivation

HemOnc Today, March 10, 2011
ASCO 2011 Genitourinary Cancers Symposium ORLANDO — Intermittent androgen suppression therapy yielded similar OS outcomes as continuous androgen…
Meeting News CoverageMeeting HighlightsPerspective

FOLFOX plus cetuximab produced ORR of 77% in cardia, esophageal cancer

HemOnc Today, February 25, 2011
2011 Gastrointestinal Cancers Symposium SAN FRANCISCO – Chemoradiation with FOLFOX and cetuximab was effective in adults with locally advanced…
Meeting News CoverageMeeting Highlights

FDG-PET identified early response to chemotherapy in rare esophageal cancer

HemOnc Today, February 10, 2011
2011 Gastrointestinal Cancers Symposium FDG-PET imaging detected early metabolic response to chemotherapy in patients with locally advanced…
Meeting News CoverageMeeting HighlightsPerspective

IMRT produced less toxicity, similar outcomes as conventional radiation in anal cancer

HemOnc Today, February 10, 2011
2011 Gastrointestinal Cancers Symposium SAN FRANCISCO — Chemotherapy with dose-painted intensity-modulated radiation therapy for anal cancer…
Meeting News CoverageMeeting Highlights

Sorafenib viable option in treating drug-resistant GIST

HemOnc Today, February 10, 2011
2011 Gastrointestinal Cancers Symposium SAN FRANCISCO — Sorafenib appears to be a viable treatment option for patients with gastrointestinal…
Meeting News CoverageMeeting Highlights

SWOG 0356: High gene-expression ERCC1 levels predicted poorer survival

HemOnc Today, February 10, 2011
2011 Gastrointestinal Cancers Symposium SAN FRANCISCO — Patients with stage II to III esophageal adenocarcinoma who had elevated levels of ERCC1…
Meeting News CoveragePerspective

START: S-1 plus docetaxel improved survival in subset of patients with advanced gastric cancer

January 21, 2011
2011 Gastrointestinal Cancers Symposium SAN FRANCISCO — The combination of S-1 plus docetaxel failed to meet the primary endpoint of 25%…